Second-line weekly paclitaxel in patients with inoperable non-small cell lung cancer who fail combination chemotherapy with cisplatin-Reference-Cited by-同舟云学术

Second-line weekly paclitaxel in patients with inoperable non-small cell lung cancer who fail combination chemotherapy with cisplatin

Published:2004-08 Issue:2 Volume:45 Page:227-236
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Buccheri Gianfranco,Ferrigno Domenico

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Cancer statistics, 2001;Greenlee;CA Cancer J. Clin.,2001

2. American Thoracic Society, European Respiratory Society. Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med 1998;15:320–32.

3. Chemotherapy and survival in non-small cell lung cancer. The old ‘vexata questio’;Buccheri;Chest,1991

4. Chemotherapy and survival in non-small cell lung cancer: three years later;Buccheri;Chest,1994

5. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Alberti;Br. Med. J.,1995

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study;Thoracic Cancer;2022-04-17

2. Lung Adenocarcinoma;Pulmonary Adenocarcinoma: Approaches to Treatment;2019

3. Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial;BMC Cancer;2018-07-31

4. Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer;Anti-Cancer Drugs;2017-07

5. Carcinome bronchique non à petites cellules : quelle chimiothérapie de rattrapage ?;Revue des Maladies Respiratoires Actualités;2014-09